Peptide Drugs intermediate
Insulin Glargine U500
Highly concentrated insulin glargine (500 units/mL). 5× concentration reduces injection volume. Mimics NPH-like profile due to slower absorption. Indication: insulin-resistant patients requiring high doses.
By Encyclopeptide Editorial | 1 min read
insulin-glargine-u500 peptide-drug therapeutic
Chemical Identity
| Property | Value |
|---|---|
| Name | Insulin Glargine U500 |
| Description | Highly concentrated insulin glargine (500 units/mL). 5× concentration reduces injection volume. Mimics NPH-like profile due to slower absorption. Indication: insulin-resistant patients requiring high doses. |
Mechanism of Action
Highly concentrated insulin glargine (500 units/mL). 5× concentration reduces injection volume. Mimics NPH-like profile due to slower absorption. Indication: insulin-resistant patients requiring high doses.
Clinical Significance
This peptide drug has important therapeutic applications in clinical medicine.
References
- Encyclopeptide Database. “Insulin Glargine U500” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Glargine U500 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept